Warby Parker (WRBY)

• Market cap: $3.03B
• 1 day: 3.79%
• 5 days: 4.70%
• 1 month: 8.21%
• 3 months: 76.33%
• 6 months: 60.89%
• Year to date: 68.99%
• 1 year: 99.05%
• 5 years: -53.79%
• 10 years: -53.79%
• Sector: Healthcare
• Industry: Ophthalmic Goods

About: Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Employees: 3,491

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

81% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 43

27% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 33

5% more funds holding

Funds holding: 187 [Q2] → 196 (+9) [Q3]

5% more call options, than puts

Call options by funds: $26.6M | Put options by funds: $25.4M

2% more capital invested

Capital invested by funds: $1.57B [Q2] → $1.6B (+$31M) [Q3]

1.25% less ownership

Funds ownership: 98.67% [Q2] → 97.42% (-1.25%) [Q3]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q2] → 2 (-1) [Q3]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $20 21% downside
• Avg. target: $24 6% downside
• High target: $28 11% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

JMP Securities Nicholas Jones 68% 1-year accuracy 54 / 80 met price target	11% upside $28	Market Outperform Maintained	16 Dec 2024
Stifel Jim Duffy 64% 1-year accuracy 21 / 33 met price target	21% downside $20	Hold Maintained	11 Dec 2024
Goldman Sachs Brooke Roach 66% 1-year accuracy 23 / 35 met price target	3% upside $26	Buy Maintained	10 Dec 2024
Telsey Advisory Group Dana Telsey 67% 1-year accuracy 126 / 189 met price target	3% upside $26	Outperform Maintained	19 Nov 2024
Piper Sandler Anna Andreeva 57% 1-year accuracy 21 / 37 met price target	13% downside $22	Overweight Maintained	8 Nov 2024